BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7161767)

  • 1. The effect of glucan--a host resistance activator--and ampicillin on experimental intraabdominal sepsis.
    Lahnborg G; Hedström KG; Nord CE
    J Reticuloendothel Soc; 1982 Nov; 32(5):347-53. PubMed ID: 7161767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucan-induced enhancement of host resistance in experimental intraabdominal sepsis.
    Lahnborg G; Hedström KG; Nord CE
    Eur Surg Res; 1982; 14(6):401-8. PubMed ID: 7173285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ciprofloxacin compared to gentamicin in the treatment of experimental intraabdominal infections in rats.
    Lahnborg G; Nord CE
    Scand J Infect Dis Suppl; 1989; 60():35-8. PubMed ID: 2756352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of tosufloxacin in the treatment of experimentally induced intra-abdominal infections in rats.
    Nord CE; Edlund C
    Drugs Exp Clin Res; 1992; 18(3):89-92. PubMed ID: 1425208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-glucan attenuates inflammatory cytokine release and prevents acute lung injury in an experimental model of sepsis.
    Bedirli A; Kerem M; Pasaoglu H; Akyurek N; Tezcaner T; Elbeg S; Memis L; Sakrak O
    Shock; 2007 Apr; 27(4):397-401. PubMed ID: 17414422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of intraperitoneal adhesion formation using beta-glucan after ileocolic anastomosis in a rat bacterial peritonitis model.
    Bedirli A; Gokahmetoglu S; Sakrak O; Ersoz N; Ayangil D; Esin H
    Am J Surg; 2003 Apr; 185(4):339-43. PubMed ID: 12657386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of one prophylactic dosage of antibiotics on experimentally induced lethal intraabdominal sepsis.
    Brolin J; Lahnborg G; Nord CE
    Acta Chir Scand; 1984; 150(3):239-44. PubMed ID: 6380178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dietary beta-1,3 glucan on immune responses and disease resistance of healthy and aflatoxin B1-induced immunocompromised rohu (Labeo rohita Hamilton).
    Sahoo PK; Mukherjee SC
    Fish Shellfish Immunol; 2001 Nov; 11(8):683-95. PubMed ID: 11759039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucan enhances survival in an intraabdominal infection model.
    Bowers GJ; Patchen ML; MacVittie TJ; Hirsch EF; Fink MP
    J Surg Res; 1989 Aug; 47(2):183-8. PubMed ID: 2755122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGG-glucan, a leukocyte-specific immunostimulant, does not potentiate GVHD or allograft rejection.
    Washburn WK; Otsu I; Gottschalk R; Monaco AP
    J Surg Res; 1996 May; 62(2):179-83. PubMed ID: 8632636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different antimicrobial agents in treatment and prophylaxis of experimentally induced intraabdominal sepsis.
    Lahnborg G; Nord CE
    Scand J Gastroenterol Suppl; 1984; 100():10-5. PubMed ID: 6592741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auto-cross-linked hyaluronic acid gel does not reduce intra-abdominal adhesions or abscess formation in a rat model of peritonitis.
    Sikkink CJ; de Man B; Bleichrodt RP; van Goor H
    J Surg Res; 2006 Dec; 136(2):255-9. PubMed ID: 17059836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
    Cheung NK; Modak S
    Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic modification of Escherichia coli--induced experimental peritonitis and bacteremia by glucan.
    Williams DL; Browder IW; Di Luzio NR
    Surgery; 1983 Mar; 93(3):448-54. PubMed ID: 6338616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection by aminated glucan in experimental endogenous peritonitis.
    Almdahl SM; Bøgwald J; Hoffman J; Giercksky KE; Seljelid R
    Eur Surg Res; 1987; 19(2):78-85. PubMed ID: 3545847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble beta-1,3/1,6-glucan from yeast inhibits experimental periodontal disease in Wistar rats.
    Breivik T; Opstad PK; Engstad R; Gundersen G; Gjermo P; Preus H
    J Clin Periodontol; 2005 Apr; 32(4):347-52. PubMed ID: 15811050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthrax-protective effects of yeast beta 1,3 glucans.
    Kournikakis B; Mandeville R; Brousseau P; Ostroff G
    MedGenMed; 2003 Mar; 5(1):1. PubMed ID: 12827062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of experimental peritonitis in rats by transfer of peritoneal mononuclear cells from rats injected with semisoluble aminated glucan.
    Almdahl SM; Bøgwald J; Hoffman J; Seljelid R
    Acta Chir Scand; 1987 Sep; 153(9):535-9. PubMed ID: 3321808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dietary beta-1, 3 glucan on innate immune response of large yellow croaker, Pseudosciaena crocea.
    Ai Q; Mai K; Zhang L; Tan B; Zhang W; Xu W; Li H
    Fish Shellfish Immunol; 2007 Apr; 22(4):394-402. PubMed ID: 16928452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of heparinization on intra-abdominal infection and acute pulmonary failure.
    Sun Y; Williams CH; Hardaway RM; Shen J
    Int Surg; 1997; 82(4):367-70. PubMed ID: 9412832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.